Trade Mark Journal No.2026/013 27 March 2026
WO0000001892612 (5)
Office of origin: United States of America
Date of International Registration:21 November 2025
Date of designation in the UK:
21 November 2025

International priority date claimed: 22 May 2025
(United States of America)
(99197944)
- Class 5
- Medicinal preparations for the treatment and prevention of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the treatment of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the prevention of lymphopenia, cancer, and infectious diseases; biological preparations for the prevention and treatment of lymphopenia, cancer, and infectious diseases; vaccines.
ImmunityBio, Inc.
Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA